[1]
|
李思佳, 李曼曼, 刘慧, 等. Ki-67表达在三阴性乳腺癌患者预后中价值分析[J]. 中国医师进修杂志, 2019, 42(5): 392-395. https://doi.org/10.3760/cma.j.issn.1673-4904.2019.05.003
|
[2]
|
刘佳静, 黄桂春, 王文艺, 等. 化疗联合PD-(L)1单抗治疗晚期三阴性乳腺癌的研究进展[J]. 现代肿瘤医学, 2023, 31(6): 1156-1161. https://doi.org/10.3969/j.issn.1672-4992.2023.06.035
|
[3]
|
Lionti, S., La Rocca, L., Nunnari, C.M. and Barresi, V. (2018) Strong Androgen Receptor Expression Is Not Useful in Distinguishing GATA3+ Metastases. Pathology Re-search and Practice, 214, 2110-2114.
https://doi.org/10.1016/j.prp.2018.09.027
|
[4]
|
吴开良, 时倩倩, 杨壹羚, 等. GATA3在乳腺癌中的研究进展[J]. 中国现代医学杂志, 2021, 31(5): 34-38.
https://doi.org/10.3969/j.issn.1005-8982.2021.05.007
|
[5]
|
Najafabadi, M.K., Mirzaeian, E., Montazerin, S.M., et al. (2021) Role of GATA3 in Tumor Diagnosis: A Review. Pathology Research and Practice, 226, Article ID: 153611. https://doi.org/10.1016/j.prp.2021.153611
|
[6]
|
Yang, J., Zhao, X., Huang, R.Y., et al. (2021) The Role of GATA3 in Breast Cancer: An Updated Review. Current Chinese Science, 1, 608-615. https://doi.org/10.2174/2210298101666210914091839
|
[7]
|
Tsai, K.K., Chan, T.S. and Shaked, Y. (2019) Next Viable Routes to Targeting Pancreatic Cancer Stemness: Learning from Clinical Setbacks. Journal of Clinical Medicine, 8, E702. https://doi.org/10.3390/jcm8050702
|
[8]
|
Sinh, A., et al. (2019) Enhanced Induction of Apoptosis in Ha-CaT Cells by Luteolin Encapsulated in PEGylated Liposomes-Role of Caspase-3/Caspase-14. Applied Biochemistry and Biotechnology, Part A. Enzyme Engineering and Biotechnology, 188, 147-164. https://doi.org/10.1007/s12010-018-2907-z
|
[9]
|
Shan, L., Li, X., Liu, L., et al. (2014) GATA3 Cooperates with PARP1 to Regulate CCND1 Transcription through Modulating Histone H1 Incorporation. Oncogene, 33, 3205-3216. https://doi.org/10.1038/onc.2013.270
|
[10]
|
江琪, 习一清, 魏蕾. LncRNA GATA3-AS1促进乳腺癌细胞的增殖迁移及其机制[J]. 医学新知, 2022, 32(2): 127-137. https://doi.org/10.12173/j.issn.1004-5511.202202018
|
[11]
|
Schrijver, W., Schuurman, K., van Rossum, A., et al. (2018) FOXA1 Levels Are Decreased in Pleural Breast Cancer Metastases after Adjuvant Endocrine Therapy, and This Is Associated with Poor Outcome. Molecular Oncology, 12, 1884-1894. https://doi.org/10.1002/1878-0261.12353
|
[12]
|
方煜彤, 张群琛, 洪超群, 等. 乳腺癌中miR-221、miR-222表达水平对GATA3和FOXA1蛋白的影响及其作用机制[J]. 癌变•畸变•突变, 2021, 33(6): 435-441, 460. https://doi.org/10.3969/j.issn.1004-616x.2021.06.006
|
[13]
|
Si, W.Z., Huang, W., Zheng, Y., et al. (2015) Dys-function of the Reciprocal Feedback Loop between GATA3- and ZEB2-Nucleated Repression Programs Contributes to Breast Cancer Metastasis. Cancer Cell, 27, 822-836.
https://doi.org/10.1016/j.ccell.2015.04.011
|
[14]
|
Kim, K.S., Kim, J., Oh, N., et al. (2018) ELK3-GATA3 Axis Modulates MDA-MB-231 Metastasis by Regulating Cell-Cell Adhesion-Related Genes. Biochemical and Biophysical Research Communications, 498, 509-515.
https://doi.org/10.1016/j.bbrc.2018.03.011
|
[15]
|
Chou, J., Lin, J.H., Brenot, A., et al. (2013) GATA3 Suppresses Metastasis and Modulates the Tumour Microenvironment by Regulating microRNA-29b Expression. Nature Cell Biolo-gy, 15, 201-213. https://doi.org/10.1038/ncb2672
|
[16]
|
Desmedt, C., Zoppoli, G., Gundem, G., et al. (2016) Ge-nomic Characterization of Primary Invasive Lobular Breast Cancer. Journal of Clinical Oncology, 34, 1872-1881. https://doi.org/10.1200/JCO.2015.64.0334
|
[17]
|
Martin, E.M., Orlando, K.A., Yokobori, K., et al. (2021) The Es-trogen Receptor/GATA3/FOXA1 Transcriptional Network: Lessons Learned from Breast Cancer. Current Opinion in Structural Biology, 71, 65-70.
https://doi.org/10.1016/j.sbi.2021.05.015
|
[18]
|
Takaku, M., Grimm, S.A., Roberts, J.D., et al. (2018) GATA3 Zinc Finger 2 Mutations Reprogram the Breast Cancer Transcriptional Network. Nature Communications, 9, Article No. 1059. https://doi.org/10.1038/s41467-018-03478-4
|
[19]
|
钱卫东, 沈兰芳, 王婷, 等. gata3基因表达与人乳腺肿瘤病理特征的相关性分析[J]. 陕西科技大学学报, 2019, 37(4): 40-45, 63. https://doi.org/10.3969/j.issn.1000-5811.2019.04.008
|
[20]
|
Karn, R. and Emerson, I.A. (2020) Breast Cancer Muta-tion in GATA3 Zinc Finger 1 Induces Conformational Changes Leading to the Closer Binding of ZnFn2 with a Wrapping Architecture. Journal of Biomolecular Structure and Dynamics, 38, 1810-1821. https://doi.org/10.1080/07391102.2019.1620635
|
[21]
|
仲竹娟, 戚玉琴, 时潇洋. GATA3在乳腺非特殊类型浸润性导管癌中的表达及临床意义[J]. 南通大学学报(医学版), 2021, 41(1): 84-86. https://doi.org/10.16424/j.cnki.cn32-1807/r.2021.01.020
|
[22]
|
Tang, S.X., Yu, B.H., Xu, X.L., et al. (2017) Char-acterisation of GATA3 Expression in Invasive Breast Cancer: Differences in Histological Subtypes and Immunohisto-chemically Defined Molecular Subtypes. Journal of Clinical Pathology, 70, 926-934. https://doi.org/10.1136/jclinpath-2016-204137
|
[23]
|
McDonald, T.M. and Epstein, J.I. (2021) Aberrant GATA3 Staining in Prostatic Adenocarcinoma. American Journal of Surgical Pathology, 45, 341-346. https://doi.org/10.1097/PAS.0000000000001557
|
[24]
|
Byrne, D.J., Deb, S., Takano, E.A., et al. (2017) GATA3 Expression in Triple-Negative Breast Cancers. Histopathology, 71, 63-71. https://doi.org/10.1111/his.13187
|
[25]
|
袁静萍, 吴娟, 余鑫鑫, 等. GATA3、MGB和GCDFP-15在乳腺癌中的病理诊断价值[J]. 中华内分泌外科杂志, 2020, 14(2): 94-99. https://doi.org/10.3760/cma.j.issn.115807-20190925-00182
|
[26]
|
Kimura, N., Shiga, K., Kaneko, K., et al. (2020) The Diagnostic Dilemma of GATA3 Immunohistochemistry in Pheochromocytoma and Para-ganglioma. Endocrine Pathology, 31, 95-100.
https://doi.org/10.1007/s12022-020-09618-1
|
[27]
|
Boto, A. and Harigopal, M. (2018) Strong Androgen Receptor Expression Can Aid in Distinguishing GATA3+ Metastases. Human Pathology, 75, 63-70. https://doi.org/10.1016/j.humpath.2018.01.024
|
[28]
|
Malinee, M., Kumar, A., Hidaka, T., et al. (2019) Targeted Suppression of Metastasis Regulator Transcription Factor SOX2 in Various Cancer Cell Lines Using a Se-quence-Specific Designer Pyrrole-Imidazole Polyamide. Bioorganic & Medicinal Chemistry, 6, Article ID: 115248. https://doi.org/10.1016/j.bmc.2019.115248
|
[29]
|
李佳艺, 游雪叶, 叶煌阳, 等. 三阴乳腺癌原发灶和转移灶中ER-u36、EpCAM、SOX2的表达及临床意义[J]. 中国老年学杂志, 2017, 37(17): 4190-4192.
|
[30]
|
Kamarlis, R.K., Lubis, M.N., Hernowo, B.S., et al. (2017) Immunoexpression of P63 and SOX2 in Triple-Negative Breast Cancers, In-donesia. F1000Research, 6, Article No. 1780. https://doi.org/10.12688/f1000research.12671.1
|
[31]
|
张晶, 王崇杰, 门康, 等. 基于生物信息学方法分析SOX11与乳腺癌患者临床参数、预后的关系及其调控通路[J]. 山东医药, 2022, 62(11): 24-27. https://doi.org/10.3969/j.issn.1002-266X.2022.11.006
|
[32]
|
Wang, Y., Zhou, J., Wang, Z., et al. (2017) Upregulation of SOX2 Activated LncRNA PVTl Expression Promotes Breast Cancer Cell Growth and Inva-sion. Biochemical and Biophysical Research Communications, 493, 429-436.
https://doi.org/10.1016/j.bbrc.2017.09.005
|
[33]
|
Dey, A., Kundu, M., Das, S., Jena, B.C. and Mandal, M. (2022) Understanding the Function and Regulation of SOX2 for Its Therapeutic Potential in Breast Cancer. Biochimica et Bio-physica Acta (BBA)—Reviews on Cancer, 1877, Article ID: 188692. https://doi.org/10.1016/j.bbcan.2022.188692
|
[34]
|
Zhang, J., Lv, X., Wei, B., Gong, X. and Chen, L. (2022) CHD4 Mediates SOX2 Transcription through TRPS1 in Luminal Breast Cancer. Cell Signal, 100, Article ID: 110464. https://doi.org/10.1016/j.cellsig.2022.110464
|
[35]
|
陆宇云, 黄梅, 石新蕾, 等. 2011至2020年乳腺癌干细胞Web of Science数据库的文献计量学与可视化分析[J]. 中国组织工程研究, 2021, 25(25): 4001-4008.
|
[36]
|
Zhou, L., Zhao, L.C., Jiang, N., et al. (2017) MicroRNA miR-590-5p Inhibits Breast Cancer Cell Stemness and Metastasis by Targeting SOX2. European Review for Medical & Pharmacological Sciences, 21, 87-94.
|
[37]
|
牟雯君. SOX2对肿瘤微环境中巨噬细胞功能的影响与调节[D]: [硕士学位论文]. 天津: 南开大学, 2011.
https://doi.org/10.7666/d.y2001895
|
[38]
|
Zhou, C., Wang, D., Li, J., Wang, Q., Wo, L., Zhang, X., Hu, Z., et al. (2022) TGFB2-AS1 Inhibits Triple-Negative Breast Cancer Progression via Interaction with SMARCA4 and Regulating Its Targets TGFB2 and SOX2. Proceedings of the National Academy of Sciences of the United States of America, 119, e2117988119.
https://doi.org/10.1073/pnas.2117988119
|
[39]
|
Dittmer, A. and Dittmer, J. (2020) Carcinoma-Associated Fibro-blasts Promote Growth of SOX2-Expressing Breast Cancer Cells. Cancers (Basel), 12, Article No. 3435. https://doi.org/10.3390/cancers12113435
|
[40]
|
Peng, W., Chang, L., Li, W., Liu, Y. and Zhang, M. (2022) OCT4 and SOX2 Specific Cytotoxic T Cells Exhibit Not Only Good Efficiency but Also Synergize PD-1 Inhibitor (Nivolumab) in Treating Breast Cancer Stem-Like Cells and Drug-Resistant Breast Cancer Mice. Frontiers in Oncology, 12, Article ID: 781093.
https://doi.org/10.3389/fonc.2022.781093
|
[41]
|
张鹏, 徐洪燕, 孙勇. SOX2和ABCC5在乳腺癌中的表达及与化疗敏感性的关系[J]. 河北医药, 2020, 42(5): 645-649. https://doi.org/10.3969/j.issn.1002-7386.2020.05.001
|
[42]
|
Tang, W., Zhang, X., Tan, W., et al. (2019) miR-145-5p Suppresses Breast Cancer Progression by Inhibiting SOX2. Journal of Surgical Research, 236, 278-287. https://doi.org/10.1016/j.jss.2018.11.030
|